Galectin Therapeutics Inc. (NASDAQ:GALT)
CAPS Rating:
A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.
RSS Headlines
Fool UK
Recs
take any recent gains now or you will develop groans to replace the gains